Ambrx Biopharma, Inc. (CIK: 0001990550) EDGAR, Information, Filings... CompaniesBIO.Com

Ambrx Biopharma, Inc.

Mailing address
10975 NORTH TORREY PINES ROAD, LA JOLLA, Delaware, 92037
Phone
(858) 875-2400
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Ambrx Biopharma, Inc. (CIK: 0001990550) is an American company incorporated in the state of California. Head office is located at 10975 NORTH TORREY PINES ROAD, LA JOLLA, California, 92037. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Ambrx Biopharma, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

New Ambrx Biopharma Inc. from 2023-25-Aug to 2023-15-Sep

Owner	Filings	Transaction Date	Type of Owner
O'Connor Daniel J.	0001376847	Oct-27-2023	director, officer: President and CEO
Nelson Sonja	0001674905	Oct-27-2023	officer: Chief Financial Officer
Cormorant Asset Management, LP	0001583977	Oct-23-2023	10 percent owner
Chen Bihua	0001599214	Oct-23-2023	10 percent owner
Cormorant Global Healthcare Master Fund, LP	0001618442	Oct-23-2023	10 percent owner
Cormorant Private Healthcare Fund III LP	0001817320	Oct-23-2023	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Ambrx Biopharma, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001172661-24-004740 (34 Act) Size: KB	Nov-14-2024	005-94206 241458191
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000950157-24-000430 (34 Act) Size: KB	Mar-18-2024	000-56600 24758491
8-K	Document	Current report filing Acc-no: 0000950157-24-000386 (34 Act) Size: KB	Mar-12-2024	000-56600 24743015
EFFECT	Document	Acc-no: 9999999995-24-000625 (33 Act) Size: KB	Mar-08-2024	333-275053 24736425
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-24-063394 (33 Act) Size: KB	Mar-08-2024	333-274952 24733545
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-24-063386 (33 Act) Size: KB	Mar-08-2024	333-271966-01 24733517
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-24-063378 (33 Act) Size: KB	Mar-08-2024	333-271005-01 24733493
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-24-063372 (33 Act) Size: KB	Mar-08-2024	333-264490-01 24733475
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-24-063370 (33 Act) Size: KB	Mar-08-2024	333-257264-01 24733456
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-028250 ( Act) Size: 0 KB	Mar-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-028242 ( Act) Size: 0 KB	Mar-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-028190 ( Act) Size: 0 KB	Mar-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-028188 ( Act) Size: 0 KB	Mar-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-028186 ( Act) Size: 0 KB	Mar-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-028182 ( Act) Size: 0 KB	Mar-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-028177 ( Act) Size: 0 KB	Mar-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-028171 ( Act) Size: 0 KB	Mar-07-2024
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001193125-24-061871 (33 Act) Size: KB	Mar-07-2024	333-275053 24729293
25-NSE/A	Document	Acc-no: 0001354457-24-000131 (34 Act) Size: KB	Mar-07-2024	000-56600 24728393
8-K	Document	Current report filing Acc-no: 0001193125-24-061543 (34 Act) Size: KB	Mar-07-2024	000-56600 24728276

Recent 20 filings. View all Ambrx Biopharma, Inc. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Ambrx Biopharma, Inc. overview
Ambrx Biopharma, Inc. job
Ambrx Biopharma, Inc. stock
Ambrx Biopharma, Inc. ownership
Ambrx Biopharma, Inc. CEO
Ambrx Biopharma, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.